Skip to main content
Eli Lilly and Company
Healthcare · Drug Manufacturers - General
Made on Jul 30, 2026
Price at call $1,210.02
6-month call Bear -5.4%
Target by Jan 2027 $1,145.00
Great value below $950.00
Model v0.6.0

Projection vs Actual (6M history + forecast)

The masterbrain's trajectory (blue, curved through its 7 checkpoints), the deterministic v0.3 control (dashed), and the actual price (green) overlaid from the prediction date forward.
Forecast Change -5.4% to $1,145.00
Predicted High $1,188.00 in 2 weeks
Predicted Low $1,140.00 at 4 months
Max Drawdown (predicted) -5.8%

Forecast

The masterbrain trajectory — 7 dated checkpoints. Short rungs (2w, 1m) show the typical range as the primary claim; point calls run from 2 months out. Every claim still gets graded. Predicted Jul 30, 2026 1:08 am
Bear LLY trends lower to $1,145.00 (-5.4% from $1,210.02) by Jan 2027. decay
ThesisLLY trades far above the only available anchor (bear scenario ~$435) with negative value lens and softening GLP-1 narrative, but quality is elite and beta is very low, cushioning near-term downside. Expect modest drift lower over 6 months as competitive pressure compresses the premium, with a stress-regime wobble first and stabilization as the name finds defensive bid.
Invalidated ifA decisive GLP-1 competitive win (Phase 3 obesity readout, tirzepatide label expansion) or LLY breaking above $1,300 on volume invalidates the fade; conversely a break under $1,050 accelerates it.
Checkpointtime after the call Datewhen it gets graded Predictedthe claim: closing price Current priceactual close — fills in over time Predicted returnpredicted vs $1,210.02 at call Conv.brain's confidence, 1–10 Driverwhy the brain put the point here
Prediction made Jul 30, 2026 $1,210.02 at call The anchor — every point below is measured from this price and date.
2 weeks Aug 13, 2026 $1,123.74–$1,296.30 typical range · internal point $1,188.00 ±7.1% 6/10 Stress regime bleeds low-beta defensive slightly lower
What actually happened: closed $1,220.28 on Aug 12, 2026 = +0.9% vs the call (predicted -1.8%)  ·  direction HIT (called flat, was flat)  ·  off by 2.7 pp  ·  accuracy 9/10  ·  typical range ±7.1%: inside the band  ·  S&P +4.2% over the same window — beat it
1 month Aug 30, 2026 $1,084.98–$1,335.06 typical range · internal point $1,175.00 ±10.3% 5/10 Sentiment drag continues, no catalyst to reprice
2 months Sep 30, 2026 $1,160.00 -4.1% 5/10 GLP-1 competitor headlines pressure premium multiple
3 months Oct 30, 2026 $1,150.00 -5.0% 4/10 Q3 print window; quality supports but value gap weighs
4 months Nov 30, 2026 $1,140.00 -5.8% 4/10 Gradual mean reversion toward fair-value gravity
5 months Dec 30, 2026 $1,155.00 -4.5% 3/10 Year-end defensive rotation offers modest bid
6 months Jan 30, 2027 $1,145.00 -5.4% 3/10 Path uncertain; value overhang persists into 2027

Why ranges on the short rungs? A 102-prediction trial (2026-07-21) showed 2-week point calls carry no information here — three prompt formulations all lost to simply predicting zero — while the stock's own volatility scale (σ×√t) described those windows well. So the short rungs claim what's actually knowable: the typical travel, with earnings timing flagged where the variance will come from. The internal point calls keep being generated and graded to map where real skill begins. Full evidence: stocks/predictions/V0.5-DESIGN.md §8.

Deterministic control (v0.3 value line) targets $0.00 (+0.0%) — both lines get graded at every checkpoint, so the brain has to beat the formula, not just replace it. Brain: claude-opus-4-7.

Weaknesses

0 blocking · 1 degraded · 5 notes — follow the chain top-down (cause → effect).
  • Degraded
    No usable fair-value anchor — brain-only (anchorless) mode: no v0.3 control line, prediction reasons from lenses/sentiment/regime/price behaviour.
    value_anchor
  • Note
    EPV de-weighted — growth IS the value proposition for this type of company
    upstream:classification
  • Note
    Valuation anchor absent: composite_fair_value.
    anchor:composite_fair_value
  • Note
    Valuation anchor absent: dcf.
    anchor:dcf
  • Note
    Valuation anchor absent: anchored_pe.
    anchor:anchored_pe
  • Note
    Valuation anchor absent: signal_adjusted.
    anchor:signal_adjusted

Equation Inputs

Everything feeding the v0.6.0 model — value anchors, the stock's own price behaviour, and the tunable knobs.

Value anchors (from deep analysis)

Price at call$1,210.02
Composite fair value
Signal-adjusted fair value
DCF fair value
Anchored-PE fair value
Buy-below (value lens)
Value net score-72
Value confidence7 / 10
Quality net score+86
Memo confidence— / 10
Deserved value (base)
Quality tilt
Deserved value (used)
Coherence (value × quality)

Price behaviour (trailing — shapes the realism line)

Realized volatility (annualized) 1m 26.9%  3m 35.8%  6m 38.5%  
Daily σ (realism noise)2.3%
Beta vs S&P 500 1m -0.45  3m 0.23  5m 0.51  
Trailing 6-month return16.4%

Knobs (equation params)

ladderArray
llm_modelclaude-opus-4-7
max_tokens3000
control_knobsArray
Neutral band (%)5
earnings_briefv1
prompt_versionp1
control_versionv0.3.0

Version & Tech Chain

What produced this prediction — stamped on the record so versions can be compared by success rate later.
Model v0.6.0 #8eb3df85c300

Tech composition (what this version is built from)

#ProcessKindGroup
1 Synthesis valuation-synthesis deterministic final
2 Scenario Analysis scenario-valuation deterministic valuation
3 Valuation / Mispricing ext-lens-value llm extended
4 Company Quality ext-lens-quality llm extended
5 Forensic Memo (combiner) ext-forensic-memo llm extended
6 Classification company-classification llm foundation
7 Live Quote fmp-quote data market-data

Inputs used (the runs that fed this prediction)

Upstream processRanLagRun id
company-classification Jul 30, 2026 freshest LLY-20260730-001020-b9e7
ext-forensic-memo Jul 30, 2026 freshest ext-LLY-20260730-005820-720e
ext-lens-quality Jul 30, 2026 freshest ext-LLY-20260730-005820-720e
ext-lens-sentiment Jul 30, 2026 freshest ext-LLY-20260730-005820-720e
ext-lens-value Jul 30, 2026 freshest ext-LLY-20260730-005820-720e
scenario-valuation Jul 30, 2026 freshest LLY-20260730-001020-b9e7
valuation-synthesis Jul 30, 2026 freshest LLY-20260730-001020-b9e7

Inputs flagged 7d+ behind the freshest one may be stale relative to the rest of the analysis.

Saved History

2 frozen snapshots — the record we score once predictions mature.
MadeModelCallAt callTargetExp.Eval due
Jul 30, 2026 v0.6.0 Bear $1,210.02 $1,145.00 -5.4% Jan 2027 viewing
Jun 24, 2026 v0.3.0 view

Not Yet Modeled

What this v0.6.0 forecast deliberately ignores — the work ahead, in plain sight.
  • Scenario probabilities — one path, no bull/bear split (base_prob = 1.0).
  • Intraday / sub-2-week behaviour — the first claim is at 14 days by design (EOD product).
  • Position sizing / portfolio context — the path is a price claim only.